Suhail Ahmad Mir

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Estrogen Receptor

Top Venues

Pharmaceuticals (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sonali S Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, Umme Hani, Afreen Khanam, Faisal Ashraf Bhat, Suhail Ahmad Mir, Mohammed Y Ghazwani, Shadma Wahab, Nazima Haider, Abdulrahman A Al-Mehizia
Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. Biology 12 (3) (2023)
Sonali S Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, Umme Hani, Afreen Khanam, Faisal Ashraf Bhat, Suhail Ahmad Mir, Mohammed Y Ghazwani, Shadma Wahab, Nazima Haider, Abdulrahman A Al-Mehizia
Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. Biology 12 (3) (2023)
Suhail Ahmad Mir, Ashraf Dar, Saad Ali Alshehri, Shadma Wahab, Laraibah Hamid, Mohammad Ali Abdullah Almoyad, Tabasum Ali, Ghulam Nabi Bader
Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Suhail Ahmad Mir, Laraibah Hamid, Ghulam Nabi Bader, Ambreen Shoaib, Mohamed Rahamathulla, Mohammed Y Alshahrani, Prawez Alam, Faiyaz Shakeel
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review. Molecules (Basel, Switzerland) 27 (19) (2022)
Suhail Ahmad Mir, Rifat Ara, Fiza Amin, Anjum Malik, Laraibah Hamid, Tabasum Ali, Ghulam Nabi Bader, Shahid Ud Din Wani, Mansour Almuqbil, Sultan M Alshehri, Abdulhakeem M Alshehri, Faiyaz Shakeel
Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial. Medicina (Kaunas, Lithuania) 58 (11) (2022)